18 December 2024NewsAmericasMithu Sherin Director of Intellectual Property ALX Oncology, David Diamond VP & Head of Intellectual Property Capstan Therapeutics, Alexander Trimble Member Mintz, Siegmund Gutman Chair Life Sciences Litigation Practice Mintz
WATCH: Beyond the obvious: novelty, non-obviousness, and the inventive step in polymorph patents and beyond
In the world of intellectual property, securing patents for innovative ideas rests heavily on the criteria of novelty, non-obviousness, and the inventive step. This panel will examine the complexities of these fundamental patent requirements in practice, with a special focus on polymorph patents and related areas. We'll explore how recent developments and legal decisions impact innovators and the IP landscape.
